Filing Details
Neuberger High Yield Strategies Fund Inc. (AMEX:NHS) filed a definitive proxy statement (DEF 14A) with the Securities and Exchange Commission on August 06, 2026.
The Financial Services company's proxy statement provides information for shareholders ahead of the annual meeting, including board nominations, executive compensation, and proposals for shareholder vote.
Market Context
Neuberger High Yield Strategies Fund Inc.'s stock currently trades at $6.07 with a market capitalization of $223.8M.
SEC filings provide mandatory disclosures that give investors access to the same material information available to institutional investors. Reviewing Neuberger High Yield Strategies Fund Inc.'s filings alongside price action and analyst commentary provides a more complete picture of the company's current situation.
All SEC filings for Neuberger High Yield Strategies Fund Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View NHS Stock Page
Frequently Asked Questions
Where can I read NHS's SEC filings?
Browse all filings on our NHS SEC filings page.
What types of SEC filings does Neuberger High Yield Strategies Fund Inc. file?
Public companies like Neuberger High Yield Strategies Fund Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.